Picture courtesy The Indian Express
New Delhi: The Drugs Controller General of India (DCGI) has granted emergency use authorization to the COVID-19 vaccine Covovax for 12-17 years age group, PTI reported on Wednesday quoting official sources.
Covovax, the Indian version of US-developed Novavax, is manufactured in this country by Serun Institute of India.
It is the fourth COVID vaccine to receive regulator’s nod for use among under-18 age group.
The other three are Bharat Biotech’s Covaxin, which is being used to vaccinate those aged between 15 and 18 years after getting clearance last December; Zydus Cadila’s ZyCov-D which became the first one to be cleared by DCGI for those above 12 in August 2021; Biological E’s Corbevax for 12-18 years approved last month.
DCGI gave the nod to Covovax for emergency use authorization among adults on December 28, 2021, but it’s yet to be included in India’s vaccination drive.
Berhampur: A stone weighing 2 kg fell from the ‘Singhadwara Gumuta’ of the Lord Jagannath…
New Delhi: Recent pictures of Space Station Commander Sunita Williams from the International Space Station…
Mumbai: Actress Rupali Ganguly recently filed a Rs 50 crore defamation case against her stepdaughter…
Chennai: Odisha will face Manipur in the semifinals of the 14th Hockey India Senior Men’s…
New Delhi: India will again ask Canada for the extradition of designated Khalistani terrorist Arshdeep Singh…
Berhampur: Police have arrested a man from West Bengal for allegedly claiming himself to be…
Mumbai: Carving a niche for himself in Bollywood was not a cakewalk for ‘The Family…
Mumbai: Mukesh Khanna’s Indian superhero series ‘Shaktimaan’ has been making headlines for quite some time…